279 related articles for article (PubMed ID: 29959224)
1. Glycation affects fibril formation of Aβ peptides.
Emendato A; Milordini G; Zacco E; Sicorello A; Dal Piaz F; Guerrini R; Thorogate R; Picone D; Pastore A
J Biol Chem; 2018 Aug; 293(34):13100-13111. PubMed ID: 29959224
[TBL] [Abstract][Full Text] [Related]
2. Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides.
Wang L; Eom K; Kwon T
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573350
[TBL] [Abstract][Full Text] [Related]
3. Site-specific glycation of Aβ1-42 affects fibril formation and is neurotoxic.
Ng J; Kaur H; Collier T; Chang K; Brooks AES; Allison JR; Brimble MA; Hickey A; Birch NP
J Biol Chem; 2019 May; 294(22):8806-8818. PubMed ID: 30996005
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Impact of Glyoxal Glycation on β-Amyloid Peptide (Aβ) Aggregation in Alzheimer's Disease.
Hu KW; Fan HF; Lin HC; Huang JW; Chen YC; Shen CL; Shih YH; Tu LH
J Phys Chem B; 2021 Jun; 125(21):5559-5571. PubMed ID: 34019761
[TBL] [Abstract][Full Text] [Related]
5. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
Gu L; Tran J; Jiang L; Guo Z
J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
[TBL] [Abstract][Full Text] [Related]
6. Internalisation and toxicity of amyloid-β 1-42 are influenced by its conformation and assembly state rather than size.
Vadukul DM; Maina M; Franklin H; Nardecchia A; Serpell LC; Marshall KE
FEBS Lett; 2020 Nov; 594(21):3490-3503. PubMed ID: 32871611
[TBL] [Abstract][Full Text] [Related]
7. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
Dong M; Zhao W; Hu D; Ai H; Kang B
ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of Inter-Molecular Interactions Between Single Aβ
Feng L; Watanabe H; Molino P; Wallace GG; Phung SL; Uchihashi T; Higgins MJ
J Mol Biol; 2019 Jul; 431(15):2687-2699. PubMed ID: 31075274
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-β metabolite sensing: biochemical linking of glycation modification and misfolding.
Fawver JN; Schall HE; Petrofes Chapa RD; Zhu X; Murray IV
J Alzheimers Dis; 2012; 30(1):63-73. PubMed ID: 22406446
[TBL] [Abstract][Full Text] [Related]
10. Interaction between amyloid beta peptide and an aggregation blocker peptide mimicking islet amyloid polypeptide.
Rezaei-Ghaleh N; Andreetto E; Yan LM; Kapurniotu A; Zweckstetter M
PLoS One; 2011; 6(5):e20289. PubMed ID: 21633500
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous in vitro formation of supramolecular beta-amyloid structures, "betaamy balls", by beta-amyloid 1-40 peptide.
Westlind-Danielsson A; Arnerup G
Biochemistry; 2001 Dec; 40(49):14736-43. PubMed ID: 11732892
[TBL] [Abstract][Full Text] [Related]
12. Electrochemistry of Alzheimer Disease Amyloid Beta Peptides.
Chiorcea-Paquim AM; Enache TA; Oliveira-Brett AM
Curr Med Chem; 2018; 25(33):4066-4083. PubMed ID: 29446720
[TBL] [Abstract][Full Text] [Related]
13. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
Nguyen P; Derreumaux P
Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation at Ser
Hu ZW; Ma MR; Chen YX; Zhao YF; Qiang W; Li YM
J Biol Chem; 2017 Feb; 292(7):2611-2623. PubMed ID: 28031462
[TBL] [Abstract][Full Text] [Related]
15. Structural differences of amyloid-β fibrils revealed by antibodies from phage display.
Droste P; Frenzel A; Steinwand M; Pelat T; Thullier P; Hust M; Lashuel H; Dübel S
BMC Biotechnol; 2015 Jun; 15():57. PubMed ID: 26084577
[TBL] [Abstract][Full Text] [Related]
16. Curcumin Dictates Divergent Fates for the Central Salt Bridges in Amyloid-β
Chandra B; Mithu VS; Bhowmik D; Das AK; Sahoo B; Maiti S; Madhu PK
Biophys J; 2017 Apr; 112(8):1597-1608. PubMed ID: 28445751
[TBL] [Abstract][Full Text] [Related]
17. NMR-based site-resolved profiling of β-amyloid misfolding reveals structural transitions from pathologically relevant spherical oligomer to fibril.
Xiao Y; Matsuda I; Inoue M; Sasahara T; Hoshi M; Ishii Y
J Biol Chem; 2020 Jan; 295(2):458-467. PubMed ID: 31771980
[TBL] [Abstract][Full Text] [Related]
18. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth.
McLaurin J; Franklin T; Zhang X; Deng J; Fraser PE
Eur J Biochem; 1999 Dec; 266(3):1101-10. PubMed ID: 10583407
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE
Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549
[TBL] [Abstract][Full Text] [Related]
20. Engineering of a peptide probe for β-amyloid aggregates.
Aoraha E; Candreva J; Kim JR
Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
